1Simons JP,Schols AM,Hoefnagels JM,et al.Effects of medroxy progesterone acetate on food intake.body composition,and resting energy expenditure in patients with advanced,no hormonesensitive cancer:a randomized,placebo-controlled trial.Cancer,1998,82(3):553-560.
3Simons JP,Schols AM,Hoefnagels JM,et al.Effects of medroxyprogesterone acetate on food intake,body cpmposition,and restingenergy expenditure in patients with advanced,nonhormone-sensitivecancer.a randomized,placebo-controlled trial[J].Cancer,1998,82(3):553～560.
4Yamshita JI,Ogawa M.Breast medroxygesterone acetate and cancer cachexia:interleukin-6 involvement[J].cancer,2000,84(2):130～135.
5Mantovni G,Maccio A,Madeddu C,et al.Immunotherapy (recombinant interleukin 2),hormone therapy(medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of respondersto previous hemotherapy[J].Int J Oncol,2001,18(2):383～891.
6Nishimura R,Nagao k,Miyayama H,et al.An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer[J].Oncology,2000.59(2):166～173.
